Literature DB >> 7887857

Carotid endarterectomy for asymptomatic carotid artery stenosis: patients with severe bilateral disease a high risk subgroup.

M Appleberg1, D Cottier, J Crozier, J Graham, R Lane.   

Abstract

Carotid endarterectomy if advised for asymptomatic disease must be associated with a low peri-operative morbidity and mortality and satisfactory long-term results. Over a 12 year period between 1978-1989 181 carotid endarterectomies were performed on 163 patients with asymptomatic carotid artery stenosis. There were 112 males and 51 females with a mean age of 64.9 years. All patients had a high-grade lesion (> 70% stenosis). The combined operative mortality and stroke rate was 2.8%. On long-term follow up six patients suffered a stroke. Only one patient however sustained a stroke in the same territory as the previously operated carotid artery. Four years following surgery 78% of patients were alive. Carotid restenosis or occlusion occurred in 8.3% of the remaining patients, all of whom were asymptomatic. All the immediate postoperative strokes occurred in patients with severe bilateral carotid artery disease. These patients with severe bilateral disease appear to constitute a high risk sub-group for peri-operative stroke. The role of 'normal pressure-hyperperfusion breakthrough' syndrome as the presumed aetiology of two of the postoperative cerebral haemorrhages is discussed.

Entities:  

Mesh:

Year:  1995        PMID: 7887857     DOI: 10.1111/j.1445-2197.1995.tb00599.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  2 in total

1.  Gender-specific risk of perioperative complications in carotid endarterectomy patients with contralateral carotid artery stenosis or occlusion.

Authors:  Jens Weise; Sascha Kuschke; Mathias Bähr
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

2.  Risk factors and preventive measures of cerebral hyperperfusion syndrome after carotid artery interventional therapy.

Authors:  Shibo Wang; Jing Han; Lei Cheng; Nengpeng Li
Journal:  Exp Ther Med       Date:  2017-07-17       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.